Cheminformatics & Drug Designing

Cheminformatics (also known as chemoinformatics, chemioinformatics and chemical informatics) is the use of computer and informational techniques applied to a range of problems in the field of chemistry. These in silico techniques are used, for example, in pharmaceutical companies in the process of drug discovery. These methods can also be used in chemical and allied industries in various other forms.

Drug design, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modelling techniques. This type of modelling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of these protein-based therapeutics have also been developed.

 

    Related Conference of Cheminformatics & Drug Designing

    April 25-26, 2024

    22nd European Pathology Congress

    London, UK
    August 21-22, 2024

    4th World Pathology Conference

    Amsterdam, Netherlands
    September 23-24, 2024

    22nd Annual Pathology Congress

    Dubai, UAE

    Cheminformatics & Drug Designing Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in